About this Journal Submit a Manuscript Table of Contents 
Journal of Osteoporosis
Volume 2011 (2011), Article ID 810697, 4 pages
doi:10.4061/2011/810697
Case Report

Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy

Ravindra Gudena, Jason Werle, and Kelly Johnston

Department of Orthopedics, University of Calgary, 711B, 3607-49 ST NW, Calgary, Alberta, T3A 2H3, Canada

Received 4 November 2010; Accepted 8 March 2011

Academic Editor: David L. Kendler

Copyright © 2011 Ravindra Gudena et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. EFFO and NOF, “Who are candidates for prevention and treatment for osteoporosis?” Osteoporosis International, vol. 7, no. 1, pp. 1–6, 1997.
  2. B. A. Lenart, A. S. Neviaser, S. Lyman et al., “Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study,” Osteoporosis International, vol. 20, no. 8, pp. 1353–1362, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. S. Neviaser, S. K. Goh, J. S. Koh, F. Edobor-Osula, and D. G. Lorich, “Low-energy femoral shaft fractures associated with alendronate use,” Journal of Orthopaedic Trauma, vol. 22, no. 5, pp. 346–350, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. E. Shane, D. Burr, P. R. Ebeling et al., “Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral Research,” Journal of Bone and Mineral Research, vol. 25, no. 11, pp. 2267–2294, 2010. View at Publisher · View at Google Scholar · View at PubMed
  5. A. S. Sayed-Noor and G. O. Sjödén, “Case reports: two femoral insufficiency fractures after long-term alendronate therapy,” Clinical Orthopaedics and Related Research, vol. 467, no. 7, pp. 1921–1926, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Visekruna, D. Wilson, and F. E. McKiernan, “Severely suppressed bone turnover and atypical skeletal fragility,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 2948–2952, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. M. Capeci and N. C. Tejwani, “Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy,” Journal of Bone and Joint Surgery. Series A, vol. 91, no. 11, pp. 2556–2561, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. Y.-C. Ha, M.-R. Cho, K. H. Park, S.-Y. Kim, and K.-H. Koo, “Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?” Clinical Orthopaedics and Related Research, vol. 468, no. 12, pp. 3393–3398, 2010. View at Publisher · View at Google Scholar · View at PubMed